Fasting Study of Oxycodone Hydrochloride 15 mg Tablets and Roxicodone™ 15 mg Tablets
Status:
Completed
Trial end date:
2003-02-01
Target enrollment:
Participant gender:
Summary
The objective of this open-label, randomized, two-period crossover study was to compare the
oral bioavailability of a Mallinckrodt test tablet formulation of oxycodone 15 mg to an
equivalent oral dose of a commercially available oxycodone tablet (Roxicodone™ 15 mg, Roxane
Laboratories, Inc.) in a test group of healthy subjects under fasting conditions.